Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grace Watson

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Frontiers in Oncology|July 17, 2020
Recognizing and Grading CAR T-Cell Toxicities: An Advanced Practitioner PerspectiveSavannah Sievers, Grace Watson, Swapna Johncy, et al.
Journal of Visualized Experiments : Jove|August 2, 2021
An Effective Mouse Model of Unilateral Renal Ischemia-Reperfusion InjuryJosé R Godoy, Grace Watson, Carly Raspante, et al.
Blood Advances|March 3, 2022
A multicenter retrospective study of polatuzumab vedotin in patients with large B-cell lymphoma after CAR T-cell therapySushanth Gouni, Allison C Rosenthal, Jennifer L Crombie, et al.
Leukemia & Lymphoma|July 12, 2020
Ibrutinib-based therapy for the treatment of marginal zone lymphoma with central nervous system involvementFateeha Furqan, Grace Watson, Felipe Samaniego, et al.
Blood Advances|July 10, 2020
Clinical efficacy of anakinra to mitigate CAR T-cell therapy-associated toxicity in large B-cell lymphomaPaolo Strati, Sairah Ahmed, Partow Kebriaei, et al.
Blood Advances|January 11, 2022
Day 30 SUVmax predicts progression in patients with lymphoma achieving PR/SD after CAR T-cell therapyAjlan Al Zaki, Lei Feng, Grace Watson, et al.
Cell Reports. Medicine|August 16, 2023
Prolonged cytopenia following CD19 CAR T cell therapy is linked with bone marrow infiltration of clonally expanded IFNγ-expressing CD8 T cellsPaolo Strati, Xubin Li, Qing Deng, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Frontiers in Oncology|July 17, 2020
Recognizing and Grading CAR T-Cell Toxicities: An Advanced Practitioner PerspectiveSavannah Sievers, Grace Watson, Swapna Johncy, et al.
Journal of Visualized Experiments : Jove|August 2, 2021
An Effective Mouse Model of Unilateral Renal Ischemia-Reperfusion InjuryJosé R Godoy, Grace Watson, Carly Raspante, et al.
Blood Advances|March 3, 2022
A multicenter retrospective study of polatuzumab vedotin in patients with large B-cell lymphoma after CAR T-cell therapySushanth Gouni, Allison C Rosenthal, Jennifer L Crombie, et al.
Leukemia & Lymphoma|July 12, 2020
Ibrutinib-based therapy for the treatment of marginal zone lymphoma with central nervous system involvementFateeha Furqan, Grace Watson, Felipe Samaniego, et al.
Blood Advances|July 10, 2020
Clinical efficacy of anakinra to mitigate CAR T-cell therapy-associated toxicity in large B-cell lymphomaPaolo Strati, Sairah Ahmed, Partow Kebriaei, et al.
Blood Advances|January 11, 2022
Day 30 SUVmax predicts progression in patients with lymphoma achieving PR/SD after CAR T-cell therapyAjlan Al Zaki, Lei Feng, Grace Watson, et al.
Cell Reports. Medicine|August 16, 2023
Prolonged cytopenia following CD19 CAR T cell therapy is linked with bone marrow infiltration of clonally expanded IFNγ-expressing CD8 T cellsPaolo Strati, Xubin Li, Qing Deng, et al.
Pageof 1